Mistral Pharma Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mistral Pharma Inc. - overview
Established
2003
Location
Dorval, QC, Canada
Primary Industry
Pharmaceuticals
About
Based in Montreal, Canada, and founded in 2003, Mistral Pharma is a pharmaceutical product development and drug delivery company that provides drug reformulation services as well as the commercialization services of existing drugs. In March 2008, Mistral Pharma raised USD 1 million in financing from investors. Mistral Pharma is a drug delivery company that specializes in the development of both generic and branded oral controlled-release pharmaceutical products. The firm’s product line includes MIST-B01, MIST-B02, MIST-B03, MIST-B04, INSTILLAGEL®, TAMALIS(TM) (Rupatadine) a new antihistamine and INSTILLAQUILL®, etc.
Current Investors
Palos Wealth Management, Dynex Capital, Grovest Investments Inc.
Primary Industry
Pharmaceuticals
Sub Industries
Drug Stores/Convenience Stores, Pharmaceutical Research & Development
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Mistral Pharma Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.